Page 114«..1020..113114115116..120130..»

Category Archives: Stem Cell Therapy

Learn about stem cell therapy and application at Vail event

Posted: January 10, 2014 at 12:51 pm

VAIL The Vail Symposium hosts Dr. Scott Brandt, Dr. Kristin Comella and Dr. Stan Jones who will lead an interactive discussion on the history, evolution, practical applications and clinical results around stem cell treatments Friday evening in Vail.

The program is part of the Symposiums ongoing Living at Your Peak series, which is dedicated to exploring new breakthroughs in medicine and helping people live healthier, more active lives.

This program fits perfectly with our Living at Your Peak series, said Tracey Flower, the Symposiums executive director. There is a lot surrounding this topic, and has been for quite some time. With recent research in a changing medical industry, it is a great topic to discuss.

An example of breakthroughs in stem cell therapy comes in the form of the record-shattering Broncos quarterback, Peyton Manning. After failed surgeries, Manning traveled to Germany to undergo stem cell treatment on his cervical spine. At 37, Manning is playing his best football.

During this educational program, panelists will discuss the evolution of the stem cell field, explain current procedures, present research and clinical findings, and talk about the potential for stem cell applications in the future.

Join the Vail Symposium at 5 p.m. Friday at the Antlers Hotel in Vail for this event, titled: Stem Cells: The Future of Medicine is Now. Space is limited; reserve your tickets at http://www.vailsymposium.org/calendar or call the Vail Symposium at 970-476-0954.

More about the panelists

Dr. Scott Brandt: Brandt, the medical director of ThriveMD in Edwards, specializes in regenerative and restorative medicine. Brandt completed his undergraduate studies at the University of Michigan at Ann Arbor, and attended medical school at Bowman Gray School of Medicine, Wake Forest University in North Carolina. He then completed his anesthesiology residency training and internship at the University of Illinois and Michael Reese Hospitals in Chicago. As a resident in anesthesiology, Brandt specialized in interventional pain management. Since 1997, this focus has kept him on the leading edge of medical innovations that provide longer lasting solutions for acute and chronic pain. The advancement of stem cell therapy, coupled with Brandts expertise in image-guided injections, has made joint rejuvenation an important part of his practice.

Dr. Kristin Comella: In 2013, Comella was named as one of the 25 most influential people in the stem cell field. She has more than 14 years of experience in regenerative medicine, training and education, research, product development and has served in a number of senior management positions with stem cell related companies. Comella has more than 12 years of cell culturing experience including building and managing the stem cell laboratory at Tulane Universitys Center for Gene Therapy. She has also developed stem cell therapies for osteoarthritis at Osiris Therapeutics. Comella has been a member of the Bioheart senior management team since 2004 and is currently serving as its chief scientific officer.

Dr. Stan Jones: Widely known for performing a ground-breaking stem cell infusion on Governor Rick Perry during a spinal surgery in 2011, Jones is a surgeon and stem cell expert. He received his bachelors degree from Texas Tech in Lubbock before earning his medical degree from the University of Texas Southwestern Medical School in Dallas. Jones continued his medical training at the University of Utah Medical School in Salt Lake City and a residency at the University of Texas Medical School at Houston. Jones was awarded a fellowship to study the lower back at Wellseley Hospital in Toronto, Canada. In addition, he served in the U.S. Army Medical Corp as a Captain. He is licensed to practice in the state of Texas and is certified by the American Board of Orthopedic Surgery.

Read the original:
Learn about stem cell therapy and application at Vail event

Posted in Stem Cell Therapy | Comments Off on Learn about stem cell therapy and application at Vail event

Stem Cell Therapy for Premature Ovarian Failure (POF)

Posted: January 9, 2014 at 4:47 am

BEIJING, Jan. 9, 2014 /PRNewswire/ -- Premature ovarian failure (POF) is an illness seen in women under 40 years old who suffer from amenorrhea. Their blood level FSH stays over 40IU/L, with E2 under the level of 100pmol/L and P under the level of 2nmol/L. Symptoms may appear to be similar to the emergence of menopause, such as anxiety, depression, irritability, varying degrees of hot flashes and sweat, vaginal dryness, decreased libido, infertility and so on. POF is a complex etiological disease, making it an intractable disorder.

Most of the estrogen within the female body is secreted by the follicle cells of the ovaries. Premature ovarian failure leads to follicle development stagnation, resulting in reduction of follicles. The proliferation of connective tissue also results in estrogen deficiency, causing a series of clinical symptoms described.

Currently, treatment methods mainly use supplementary estrogen, which is only a temporary solution. As long-term application may cause a series of side effects such as malignant transformation, people are often looking for a permanent cure with no side effects.

Stem cell therapy brings hope for patients with premature ovarian failure. Stem cells are the cells with self-renewing and pluripotent functions. The stem cells can not only repair the tissue cells, but also regulate the immune function. The role of stem cells creates new cells regeneration treatment modalities for premature ovarian failure. Stem cell tends to reach the impaired tissues and organs, nourish and repair the lesion ovary cells in order to fulfill its recovery purpose. Many studies have shown that traditional Chinese medicine (TCM) can improve the overall condition of the body. It is helpful for increasing the survival rate of the transplanted stem cells, and make the cells act better. At ReLife, our doctors apply mesenchymal stem cells from the umbilical cord or autologous adipose tissue of patients and combine it with traditional Chinese medicine. We have achieved gratifying results of improving the quality of life for many patients. Although stem cell transplantation can be effective in the treatment of premature ovarian failure, early diagnosis and treatment are still required. Do not wait until the follicle cells have completely disappeared or are replaced by the connective tissue as it will miss the best treatment time and affect the effectiveness of stem cell treatment.

http://relifemed.com

View post:
Stem Cell Therapy for Premature Ovarian Failure (POF)

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy for Premature Ovarian Failure (POF)

West Coast Stem Cell Clinic, TeleHealth, Now Offering Stem Cell Injections for Ligament Sprains

Posted: January 7, 2014 at 7:40 am

Orange County, CA (PRWEB) January 06, 2014

Top West Coast Stem Cell Clinic, TeleHealth, is now offering stem cell injections for ligament sprains. This includes injuries of the ankle, knee, wrist and other extremity joints. Board Certified doctors administer the outpatient injections which can help patients heal quicker than conventional treatments. For more information and scheduling, call (888) 828-4575.

In adults, ligament sprains can take months to heal due to limited blood supply and healing potential. This can keep athletes off the field and inhibit the ability of even recreational athletes to walk and run without pain.

Conventional pain relief treatments are able to provide pain relief. This may include steroid injections or anti-inflammatories by mouth. However, these treatments do not alter the course of the healing.

With the advent of regenerative medicine treatments, the potential exists for quicker healing. These treatments include fat or bone marrow derived stem cell injections along with platelet rich plasma therapy.

Platelet rich plasma therapy, known as PRP therapy, involves a simple blood draw from the patient. The blood is spun in a centrifuge, which concentrates the platelets and growth factors. These are then injected into the area of ligament injury.

With the fat or bone marrow derived stem cells, the material is harvested in an outpatient procedure from the patient. It is processed immediately to concentrate the patient's stem cells and then injected right away into the injured region.

Small published studies have shown the treatment to be very effective for healing the injuries faster than with conventional treatments. There is low risk involved, the treatments are outpatient and performed by highly experienced Board Certified doctors who have over twenty years combined experience in regenerative medicine treatments.

Along with the injections for ligament injury, stem cell injections are also offered for degenerative arthritis, rotator cuff injury, back and neck pain, achilles tendonitis, plantar fasciitis and more.

TeleHealth has two offices for treatment, one in Orange and a second in Upland, CA. Call (888) 828-4575 for more information and scheduling.

Go here to read the rest:
West Coast Stem Cell Clinic, TeleHealth, Now Offering Stem Cell Injections for Ligament Sprains

Posted in Stem Cell Therapy | Comments Off on West Coast Stem Cell Clinic, TeleHealth, Now Offering Stem Cell Injections for Ligament Sprains

Beverly Hills Institute for Cellular Therapy Now Offering Revolutionary Stem Cell Face Lift Procedure at Special New …

Posted: January 6, 2014 at 3:40 am

Beverly Hills, California (PRWEB) January 06, 2014

The top stem cell clinic in Beverly Hills and Los Angeles, Beverly Hills Institute of Cellular Therapy, is now offering revolutionary stem cell facelift procedures with a New Years pricing special. The procedure involves a nonoperative technique with amniotic stem cells performed by licensed providers. No incisions are necessary, and the outpatient procedures are being offered at 20% off regular price. Call (424) 253-5577 for more information and scheduling.

Traditional facelift procedures involve anesthesia, incisions and significant healing time. A stem cell facelift procedure is performed as an outpatient with no incisions or systemic anesthesia necessary. The Beverly Hills Institute utilizes amniotic stem cells, which are processed at an FDA regulated lab and have been used over 10,000 times without adverse events.

Stem cells have the capability to eliminate wrinkles and provide the skin with a more youthful, glowing appearance. The procedure allows patients to avoid the risks of infection and no stitches are necessary. It costs considerably less than a traditional facelift and now at 20% off is a great option for those desiring to look younger without going through separate procedures for each facial area.

As individuals age, the skin tone in the facial area and texture begin to decline. Stem cells are able to rejuvenate collagen deficient areas and have the capability to change into all types of cells in a procedure that is natural, affordable and safe.

Amniotic fluid is extremely rich in stem cells, growth factors, hyaluronic acid and anti-inflammatory cells. The combination works extremely well for the stem cell facial procedure, with results that are often noticeable quickly and long lasting.

This new technology is performed by licensed aestheticians, nurses and Double Board Certified physicians at the Institute. The procedure takes less than an hour to complete. In addition to the stem cell facelift, the Institute also offers stem cell injections for numerous musculoskeletal conditions including tendon and ligament injury along with degenerative arthritis. This includes stem cell therapy for knees, shoulders and hips.

For more information and scheduling to discuss options with stem cell procedures for looking and feeling younger while avoiding surgery, call the Beverly Hills Institue for Cellular Therapy at (424) 253-5577.

Originally posted here:
Beverly Hills Institute for Cellular Therapy Now Offering Revolutionary Stem Cell Face Lift Procedure at Special New ...

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Beverly Hills Institute for Cellular Therapy Now Offering Revolutionary Stem Cell Face Lift Procedure at Special New …

Regenocyte Adult Stem Cell Therapy-Neim Malo – Video

Posted: January 4, 2014 at 4:41 pm


Regenocyte Adult Stem Cell Therapy-Neim Malo

By: RegenocyteStemCells

Continued here:
Regenocyte Adult Stem Cell Therapy-Neim Malo - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Regenocyte Adult Stem Cell Therapy-Neim Malo – Video

Regenocyte Adult Stem Cell Therapy – LouAnn Rest – Video

Posted: January 3, 2014 at 10:40 pm


Regenocyte Adult Stem Cell Therapy - LouAnn Rest
Regenocyte Adult Stem Cell Therapy an interview with patient LouAnn Rest.

By: RegenocyteStemCells

Read the original post:
Regenocyte Adult Stem Cell Therapy - LouAnn Rest - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Regenocyte Adult Stem Cell Therapy – LouAnn Rest – Video

Embryonic stem cell rejection problem fixed, study says

Posted: January 3, 2014 at 10:40 pm

One of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team.

The cells can be made invisible to the immune system by genetically engineering them to make two immune-suppressing molecules, according to the study. Researchers tested the approach in mice given a human immune system. Immune functioning in the rest of the animal remained active.

If the approach works in people, patients receiving transplanted tissue or organs made from embryonic stem cells wouldnt have to take harsh immune-suppressing drugs, said study leader Yang Xu, a UC San Diego professor of biology.

Human embryonic stem cells. The green markers indicate the presence of a protein expressed only in these cells. / Samantha Zeitlin, 2006 CIRM fellow

Researchers placed genes in the stem cells to produce the two molecules, called CTLA4-lg and PD-L1, naturally made in the body. The mice accepted transplants of heart and skin cells derived from the engineered stem cells. They rejected transplants derived from regular embryonic stem cells.

The study was published online Thursday in the journal Cell Stem Cell. Its findings will have to be confirmed for safety and effectiveness before human trials can be considered, which will take years.

Three scientists given the paper for comment had mixed reactions. While they praised the works scientific prowess, two said genetically engineering the transplanted cells could cause serious side effects that might preclude their use.

The researchers employed a clever strategy to use the immune systems natural regulatory systems, said Mitchell Kronenberg, president of the La Jolla Institute for Allergy & Immunology.

This is an especially promising approach, because it avoids the toxic side effects of the drugs now used to suppress the rejection response, and therefore this is an important step forward in showing the feasibility of using human embryonic stem cells from unrelated donors, Kronenberg said.

More skeptical were Jeanne Loring, a stem cell researcher at The Scripps Research Institute, and Craig M. Walsh, associate director of the Institute for Immunology at UC Irvine.

Here is the original post:
Embryonic stem cell rejection problem fixed, study says

Posted in Stem Cell Therapy | Comments Off on Embryonic stem cell rejection problem fixed, study says

Stem cell transplant problem solved, UCSD-led study says

Posted: January 3, 2014 at 10:40 pm

(This is my blog post about the embryonic stem cell study. For my news article about the study, go here.)

Genetically modified human embryonic stem cells can solve one of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team.

The cells can be made invisible to the immune system by genetically modifying them to make two immune-suppressing chemicals, according to a study performed in mice given a human immune system. Immune functioning in the rest of the animal remains active. The immune protection also applies to differentiated cells derived from the stem cells.

If the approach works in people, patients receiving transplanted tissue or organs made from embryonic stem cells wouldn't have to take harsh immune-suppressing drugs, said Yang Xu, a UCSD professor of biology. The method also may prevent immune rejection of tissues grown from other types of stem cells.

These arehumanized laboratory mice that contain a functional human immune system. Such mice have been used for years; a UCSD research team developed a model with a stronger immune response to test their immune-suppressing tissues. / Zhili Rong, UCSD

Researchers placed genes in the stem cells to produce the two chemicals, CTLA4-lg and PD-L1, naturally made in the body. The humanized immune systems of the mice accepted transplants of cells engineered to make the chemicals. The researchers transplanted cardiomyocytes and fibroblasts derived from the engineered stem cells. Transplants derived from regular embryonic stem cells were rejected.

The study was published online Thursday in the journal Cell Stem Cell. Its findings will have to be confirmed for safety and effectiveness in more animal studies before human trials can be considered, which will take years. The mouse model itself was "optimized" for the study to more faithfully reflect the human immune system than other immune models, the study said.

Xu said a further study is being considered in monkeys, a large animal model considered to better reflect human biology than mice.

Embryonic stem cells are being tested along with many other kinds of stem cells to replace diseased or destroyed body parts, such as spinal cord segments and insulin-producing beta cells in the pancreas. All of these cells have advantages and drawbacks. Immune rejection, along with a tendency to form tumors, are two big drawbacks to embryonic stem cells.

San Diego-based ViaCyte is preparing to test a therapy with beta cells within a year. The company encapsulates them in a permeable barrier that allows insulin to diffuse out but prevents the immune system from entering. However, that approach won't worth with transplants that must integrate into the body, such as spinal cord tissue. So a way of turning off the immune system just in those cells is an attractive idea.

Go here to read the rest:
Stem cell transplant problem solved, UCSD-led study says

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Stem cell transplant problem solved, UCSD-led study says

Chemist Direct reports continued benefits of stem cell research for potential tissue regeneration

Posted: January 3, 2014 at 10:40 pm

London (PRWEB UK) 3 January 2014

Research on how to harness the potential use of stem cells for common conditions is a worldwide subject of scientific discovery spanning over 3 decades. Incredible results in laboratory experiments have been recorded in 2013 for areas such as tissue regeneration for coronary disease, diabetes, cancer, Parkinsons and Alzheimers disease. All stem cells, whether gathered from an early embryo, a foetus or an adult, have two key properties.

Stem cells have the ability to replicate themselves as needed and can generate any specialised cells that make up the tissues and organs of the body with proper direction. This opens up an exciting potential for the generation of therapies for repair and replacement of damaged and diseased tissues and organs, as models for the testing of new drugs and helping us to understand at a cellular level what goes wrong in many conditions. 1

Stem cells derived from bone marrow or fat has been found to improve recovery from stroke in experiments using rats. This study was published in BioMed Central's open access journal Stem Cell Research & Therapy early last year. Treatment with stem cells improved the amount of brain and nerve repair and the ability of the animals to complete behavioural tasks. Using stem cell therapy holds promise for patients but there are still many questions which need to be answered, regarding treatment protocols and which cell types to use. 2

Other areas in which stem cell transplants are already being successfully used in the clinic trials are for treatment for spinal lesions and the regeneration of epidermal surfaces and in leukaemia, where stem cells are replaced during stem cell-containing bone marrow transplants. 3 These treatments demonstrate the potential of stem cells and intensive research is being performed all over the world to improve our understanding of stem cells and how these can be used therapeutically for PD.

Recently published research by a team of scientists in Wales has shown early signs of being able to regenerate damaged heart tissue. By experimenting at Cardiff and Swansea university laboratories, a team of scientists working in the private sector hopes to develop new treatments for heart failure over the next five years.

In a statement for the research team Ajan Reginald said, "We've identified what we think is a very potent type of stem cell which is heart specific. The interim analysis looks very positive and very fortunately the study does show some signs of early regeneration. What the therapy does is reproduce more cells in large numbers to regenerate the part of the heart that is damaged. The first stage of clinical trial is now completed which was focused on safety. 4

Further research during the next five years will produce more alternative solutions to diseases which currently have treatment but no permanent cures for. 5

References

1.http://www.hta.gov.uk/_db/_documents/stem_cell_pack_200806170144.pdf 2.http://www.parkinsonsnsw.org.au/assets/attachments/research/Stem-Cells.pdf 3.http://stemcellres.com/content/4/1/11 4.http://www.bbc.co.uk/news/uk-wales-25560547 5.http://www.cell.com/stem-cell-reports/abstract/S2213-6711(13)00126-4#Summary

Here is the original post:
Chemist Direct reports continued benefits of stem cell research for potential tissue regeneration

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Chemist Direct reports continued benefits of stem cell research for potential tissue regeneration

Regenocyte Adult Stem Cell Therapy -Howard Lindeman – Video

Posted: January 2, 2014 at 2:41 pm


Regenocyte Adult Stem Cell Therapy -Howard Lindeman

By: RegenocyteStemCells

Read more here:
Regenocyte Adult Stem Cell Therapy -Howard Lindeman - Video

Posted in Stem Cell Therapy | Comments Off on Regenocyte Adult Stem Cell Therapy -Howard Lindeman – Video

Page 114«..1020..113114115116..120130..»